Compounds that act on mechanisms associated with resistance of glioblastoma stem cells show efficacy in mouse models.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells
BMC Cancer Open Access 29 December 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bao, S. et al. Nature 444, 756–760 (2006).
Piccirillo, S.G. et al. Nature 444, 761–765 (2006).
Stupp, R. et al. N. Engl. J. Med. 352, 987–996 (2005).
Singh, S.K. et al. Nature 432, 396–401 (2004).
Phillips, T.M., McBride, W.H. & Pajonk, F. J. Natl. Cancer Inst. 98, 1777–1785 (2006).
Hegi, M.E. et al. N. Engl. J. Med. 352, 997–1003 (2005).
Potti, A. et al. Nat. Med. 12, 1294–1300 (2006).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Stupp, R., Hegi, M. Targeting brain-tumor stem cells. Nat Biotechnol 25, 193–194 (2007). https://doi.org/10.1038/nbt0207-193
Issue Date:
DOI: https://doi.org/10.1038/nbt0207-193
This article is cited by
-
Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells
BMC Cancer (2017)
-
Hypothermia Stimulates Glioma Stem Spheres to Spontaneously Dedifferentiate Adjacent Non-stem Glioma Cells
Cellular and Molecular Neurobiology (2015)
-
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
Oncogene (2010)
-
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
Oncogene (2008)